You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
Type 2s who take thiazolidinediones (TZDs) such as Avandia and Actos face an increased risk of heart failure, and researchers suggest that physicians should consider alternative therapies.
Researchers studied health insurance claims between 1995 and 2001 for two groups, one with about 5,500 patients who used oral TZDs and another group of 28,100 who did not. Those on TZDs tended to be younger but also more likely to experience coronary artery disease or diabetes complications.
TZD patients experienced an 8.2 percent rate of heart failure compared with 5.3 percent in the control group.
The researchers urge physicians to be alert for symptoms of congestive heart failure, such as shortness of breath, in patients on TZDs and to consider different therapies for patients at risk.
Diabetes Care, November 2003
0 comments - Mar 1, 2004
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.